Journal of Gynecologic Oncology

Korean Society of Gynecologic Oncology (대한부인종양학회)
권호 표지

Assessment and research of quality of life in gynecologic cancer patients

부인암환자의 삶의 질 평가 및 연구

Yun, Young-Ho
윤영호

  • Published : 2005.09.20
⟨ Previous Next ⟩

Abstract

Recently, advances and complexity in the treatment of gynecologic cancer cause not only improvement of tumor response and survival but also increase of interest in quality of life (QOL). However, there were relatively few research studies that reported data on QOL in gynecologic cancer patients and the impact of various treatments on QOL in the patients. Considering high morbidity and severe risk of QOL in gynecologic cancer patients, more focus and researches have to be done in issues of QOL. Especially, comprehensive-physical, emotional, social, spiritual- assessments with valid QOL assessment tool should be taken into account in multi-center clinical trials and development of intervention programs for gynecologic cancer patients.

Keywords

References

  1. Testa MA, Simonson D. Assessment of quality of life outcomes. NEJM 1996; 334: 835-9 https://doi.org/10.1056/NEJM199603283341306
  2. Gotay CC, Muraoka MY. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 1998;90: 656-67 https://doi.org/10.1093/jnci/90.9.656
  3. Stark GV, Selby P. Quality of life Instruments in oncology. Eur J Cancer 1999; 35: 1571-80 https://doi.org/10.1016/S0959-8049(99)00193-8
  4. Johnson JR, Temple R. Food and Drug Administration requirement for approval of new anticancer drugs. Cancer Treat Rep 1985; 69: 1155-7
  5. ASCO. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996; 14: 671-9 https://doi.org/10.1200/JCO.1996.14.2.671
  6. Pearman T. Quality of life and psychosocial adjustment in gynecological cancer survivors. Health and Quality of Life Outcome 2003; 1: 1-6 https://doi.org/10.1186/1477-7525-1-1
  7. Waggoner SE. Cervical cancer. Lancet 2003; 361: 2217-25 https://doi.org/10.1016/S0140-6736(03)13778-6
  8. Wenzel L, Vergote I, Cella D. Quality of life in patients receiving treatment for gynecologic malignancies: special consierations for patient care. nt J Gynaecol Obstet. 2003;83: S211-29
  9. Bawen-Enqquist K, Paskett, ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Cervical cancer; behavioral factors related to screening, diagnosis, and survivors' quality of life. Cancer 2003; 98: S2009-14 https://doi.org/10.1002/cncr.11681
  10. Moinpour CM, Feigel P, Metch B, Hayden KA, Meyskens FL, Crowley J. Quality of life end points in cancer clinical trials: reivew and recommendations. J Natl Cancer Inst 1989;81: 485-95 https://doi.org/10.1093/jnci/81.7.485
  11. Yun YH, Heo DS, Heo BY, Yoo TW, Bae JM, Ahn SH. Development of terminal cancer prognostic score as an index in terminally ill cancer patients. Oncol Rep 2001; 8: 795-800
  12. Shadbolt B, Baarresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol 2002; 20: 2514-9 https://doi.org/10.1200/JCO.2002.08.060
  13. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trialsguidelines and a checklist for protocol writers: the U.K. Medical Resarch Council Experience
  14. Osoba D, Rodrigues, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-44 https://doi.org/10.1200/JCO.1998.16.1.139
  15. P. Fayers, N. Aaronson, K. Bjordal, M. Groenvold, D. Curran and A. Bottomley, EORTC QLQ Scoring manual. 3rd ed. Brusel, 2002
  16. Available at http://www.eortc.be/home/qol/ [Last accessed; August 29, 2005.]
  17. Yun, YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Quality of Life Research 2004; 13:863-8 https://doi.org/10.1023/B:QURE.0000021692.81214.70
  18. Available at http://www.facit.org/ [Last accessed; August 29, 2005.]
  19. Levine MN, Ganz PA. Beyond the development of quality of life instruments: where do we go from here. JCO 2002; 20: 2215-6 https://doi.org/10.1200/JCO.2002.20.9.2215
  20. T. Young, H. de Haes, D. Curran, P. Fayers, Y. Brandberg, V. Vanvoorden and A. Bottomley. Guidelines for assessing quality of life in EORTC clinical trials. 1st ed. ed. Brusel, 2002
  21. Cella D. The Functional Assessment of Cancer Therapy-Lung and Lung Cancer Subscale assess quality of life and meaningful symptom improvement in lung cancer. Semin in Oncol 2004; 31(suppl 9): 11-5
  22. Steer CB, Marx GM, Galani E, Harper PG, Khayat D. Quality of life: it's never too late. JCO 2002; 20: 2915-7 https://doi.org/10.1200/JCO.2002.20.13.2915
  23. Gotay CC, Korn EL, McCave, Moore TD, Cheson BD. Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 1992;84:575-9 https://doi.org/10.1093/jnci/84.8.575
  24. Wenzel L, Huang HQ, Monk BJ, Rose PG, Cella D. Quality-of-Life Comparisons in a Randomized Trial of Interval Secondary Cytoreduction in Advanced Ovarian Carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 5605-12 https://doi.org/10.1200/JCO.2005.08.147
  25. Monk BJ, Huang HQ, Cella D, Long HJ 3rd; Gynecologic Oncology Group Study. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 4617-25 https://doi.org/10.1200/JCO.2005.10.522
  26. Chan YM, Lee PW, Fong DY, Fung AS, Wu LY, Choi AY, et al. Effect of individual psychological intervention in chinese women with gynecologic malignancy: a randomized controlled trial. J Clin Oncol 2005; 23: 4913-24 https://doi.org/10.1200/JCO.2005.02.069